Cas no 547-66-0 (magnesium oxalate)
magnesium oxalate Chemical and Physical Properties
Names and Identifiers
-
- magnesium oxalate
- Magnesium oxalate (MgC2O4)
- Magnesium oxalate dihydrate
- Ethanedioic acid,magnesium salt
- magnesium oxalate dihydrate,puratronic
- MAGNESIUM PERMANGANATE HYDRATE
- Magnesiumoxalat
- Magnesiumoxalat-2-hydrat
- Oxalic acid magnesium
- Oxalic acid magnesium salt
- r (metals basis)
- Magnesiumoxalate
- Oxalic acid, magnesium salt (1:1)
- SCHEMBL48297
- DTXSID0060276
- MAGNESIUM OXALATE [MI]
- NS00080047
- MFCD00287279
- EINECS 208-932-1
- 547-66-0
- NSC-112247
- Ethanedioic acid, magnesium salt (1:1)
- UHNWOJJPXCYKCG-UHFFFAOYSA-L
- NSC 112247
- UNII-620U3O59Z6
- 620U3O59Z6
- Q15720590
- ethanedioic acid magnesium salt
- FT-0698565
- magnesium;oxalate
- Magnesium, (ethanedioato(2-)-kappaO1,kappaO2)-
- Magnesium, [ethanedioato(2-)-.kappa.O1,.kappa.O2]-
- DTXCID9041784
- Magnesium oxalate (1:1)
- Oxalic acid, magnesium salt (1:1) (8CI)
- Ethanedioic acid, magnesium salt (1:1) (9CI)
- Oxalate, Magnesium
-
- MDL: MFCD03427024
- Inchi: 1S/C2H2O4.Mg/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+2/p-2
- InChI Key: UHNWOJJPXCYKCG-UHFFFAOYSA-L
- SMILES: [Mg+2].[O-]C(C(=O)[O-])=O
Computed Properties
- Exact Mass: 113.98000
- Monoisotopic Mass: 111.9647002g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 7
- Rotatable Bond Count: 0
- Complexity: 60.5
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Topological Polar Surface Area: 80.3
Experimental Properties
- Color/Form: Not determined
- Density: 2.180?g/mL?at 25?°C(lit.)
- Melting Point: 100-113?°C(lit.)
- Water Partition Coefficient: Soluble in diluted mineral acid, water (0.038g/100g H2O ). Insoluble in organics solutions.
- PSA: 74.60000
- LogP: -0.84440
- Solubility: Not determined
- Merck: 14,5676
magnesium oxalate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB211662-100 g |
Magnesium oxalate dihydrate, 98.5%; . |
547-66-0 | 98.5% | 100 g |
€60.60 | 2023-07-20 | |
| abcr | AB211662-500 g |
Magnesium oxalate dihydrate, 98.5%; . |
547-66-0 | 98.5% | 500 g |
€114.00 | 2023-07-20 | |
| abcr | AB211662-1 kg |
Magnesium oxalate dihydrate, 98.5%; . |
547-66-0 | 98.5% | 1 kg |
€172.80 | 2023-07-20 | |
| abcr | AB211662-2,5 kg |
Magnesium oxalate dihydrate, 98.5%; . |
547-66-0 | 98.5% | 2,5 kg |
€340.80 | 2023-07-20 | |
| A FA AI SHA , SAI MO FEI SHI ER KE JI QI XIA GONG SI | 12993-2g |
Magnesium oxalate dihydrate, Puratronic?, 99.999% (metals basis) |
547-66-0 | 99.999% | 2g |
¥308.00 | 2023-04-13 | |
| A FA AI SHA , SAI MO FEI SHI ER KE JI QI XIA GONG SI | 12993-10g |
Magnesium oxalate dihydrate, Puratronic?, 99.999% (metals basis) |
547-66-0 | 99.999% | 10g |
¥1017.00 | 2023-04-13 | |
| A FA AI SHA , SAI MO FEI SHI ER KE JI QI XIA GONG SI | 12993-50g |
Magnesium oxalate dihydrate, Puratronic?, 99.999% (metals basis) |
547-66-0 | 99.999% | 50g |
¥3764.00 | 2023-04-13 | |
| A FA AI SHA , SAI MO FEI SHI ER KE JI QI XIA GONG SI | 43976-100g |
Magnesium oxalate dihydrate, 98.5+% |
547-66-0 | 98.5+% | 100g |
¥697.00 | 2023-04-13 | |
| A FA AI SHA , SAI MO FEI SHI ER KE JI QI XIA GONG SI | 43976-500g |
Magnesium oxalate dihydrate, 98.5+% |
547-66-0 | 98.5+% | 500g |
¥3483.00 | 2023-04-13 | |
| A FA AI SHA , SAI MO FEI SHI ER KE JI QI XIA GONG SI | 43976-2kg |
Magnesium oxalate dihydrate, 98.5+% |
547-66-0 | 98.5+% | 2kg |
¥11760.00 | 2023-04-13 |
magnesium oxalate Suppliers
magnesium oxalate Related Literature
-
Gan Song,Xun Zhu,Rong Chen,Qiang Liao,Yu-Dong Ding,Lin Chen RSC Adv. 2016 6 19069
-
Kai Julius Pedersen Trans. Faraday Soc. 1939 35 277
-
3. Crystallization of magnesium oxalate in aqueous solutionG. H. Nancollas,N. Purdie Trans. Faraday Soc. 1961 57 2272
-
Yingchao Hu,Yafei Guo,Jian Sun,Hailong Li,Wenqiang Liu J. Mater. Chem. A 2019 7 20103
-
5. Solvent-free synthesis of new magnesium phosphate–oxalates displaying diverse framework topologiesWei Zhang,Maoping Kang,Meng Yang,Daibing Luo,Zhien Lin CrystEngComm 2015 17 9296
Additional information on magnesium oxalate
Recent Advances in the Study of Magnesium Oxalate (547-66-0) in Chemical and Biomedical Applications
Magnesium oxalate (CAS: 547-66-0) has garnered significant attention in recent years due to its versatile applications in chemical, biological, and pharmaceutical fields. This compound, known for its unique physicochemical properties, has been the subject of numerous studies aimed at exploring its potential in drug formulation, biomaterial development, and industrial processes. The latest research highlights its role in crystallization processes, biocompatibility, and therapeutic efficacy, making it a compound of considerable interest for multidisciplinary research.
Recent studies have focused on the synthesis and characterization of magnesium oxalate to optimize its properties for specific applications. Advanced techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), and thermogravimetric analysis (TGA) have been employed to elucidate its structural and thermal stability. These investigations have revealed that magnesium oxalate exhibits excellent thermal resistance and a well-defined crystalline structure, which are critical for its use in high-temperature industrial processes and as a precursor for advanced materials.
In the biomedical sector, magnesium oxalate has shown promise as a potential therapeutic agent. Research has demonstrated its biocompatibility and low cytotoxicity, making it suitable for use in drug delivery systems and medical implants. For instance, a 2023 study published in the Journal of Biomedical Materials Research explored the use of magnesium oxalate nanoparticles for targeted drug delivery, showcasing their ability to enhance the bioavailability of poorly soluble drugs. This breakthrough could pave the way for more efficient and less invasive treatment options for chronic diseases.
Another area of interest is the role of magnesium oxalate in preventing kidney stone formation. Contrary to traditional beliefs that oxalates contribute to renal calculi, recent findings suggest that magnesium oxalate may inhibit the crystallization of calcium oxalate, the primary component of most kidney stones. A 2022 study in the journal Urology Research reported that magnesium oxalate could act as a crystallization inhibitor, reducing the risk of stone formation. This discovery has significant implications for the development of preventive therapies for nephrolithiasis.
Industrial applications of magnesium oxalate have also seen notable advancements. Its use as a catalyst in organic synthesis and as a flame retardant in polymer composites has been extensively studied. Researchers have developed novel methods to enhance its catalytic activity and flame-retardant properties, making it a cost-effective and environmentally friendly alternative to traditional materials. These innovations align with the growing demand for sustainable solutions in chemical manufacturing and materials science.
In conclusion, magnesium oxalate (547-66-0) continues to be a compound of great scientific and industrial relevance. Its multifaceted applications, from biomedical therapies to industrial catalysts, underscore its potential to address some of the most pressing challenges in chemistry and medicine. Future research should focus on scaling up production methods, improving its functional properties, and exploring new applications to fully harness its capabilities. The ongoing studies and recent breakthroughs highlighted in this brief demonstrate the compound's enduring significance in advancing both scientific knowledge and technological innovation.
547-66-0 (magnesium oxalate) Related Products
- 867-68-5(Yttrium oxalate tetrahydrate)
- 13266-82-5(Yttrium(III) oxalate nonahydrate)
- 166897-40-1(IRON(III) OXALATE HEXAHYDRATE)
- 6153-56-6(Oxalic acid dihydrate)
- 2944-66-3(diiron trioxalate)
- 252900-41-7(Yttrium ethanedioate)
- 144-62-7(Oxalic acid)
- 1047-25-2(Ferrous oxalate dihydrate)
- 6047-25-2(Iron(II) Oxalate Dihydrate)
- 516-03-0(iron(II) oxalate)